Thermo Fisher Posts 5 Percent Q3 Revenue Growth, Raises Guidance | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported 5 percent revenue growth for the third quarter, with particularly strong growth coming from its Specialty Diagnostics segment, and raised its full-year top- and bottom-line guidance.

The Waltham, Mass.-based provider of labware, research products, and diagnostics reported total revenues of $3.09 billion for the three months ended Sept. 29, up from Q3 2011 revenues of $2.93 billion. It beat analysts' consensus estimate for revenues of $2.99 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.